Targeting mTORC1 and AMPK Signaling: Potential Therapeutic Approaches for Idiopathic Pulmonary Fibrosis. Advances in World Medical Research, [S. l.], v. 2, n. 1, p. 1–20, 2026. DOI: 10.71204/99f36029. Disponível em: https://awmr.cscholar.com/article/view/1000359. Acesso em: 28 feb. 2026.